February 17, 2017

February 17, 2017

Regional Chemotherapy Technique for Extremity Sarcoma Salvages Patients’ Limbs from Amputation
American College of Surgeons – Feb. 15
The researchers used the treatment technique, known as regional chemotherapy with isolated limb perfusion (ILI), in 77 patients with treatment-resistant, locally advanced soft tissue sarcomas (STS), and were able to salvage limbs in 77.9 percent of the cases. “Isolated limb infusion is a safe and effective technique of treatment of patients with locally advanced soft tissue sarcoma who otherwise might require amputation,” said lead study author John E. Mullinax, MD, from Moffitt Cancer Center, Tampa, Fla.

Revisiting E-Cigarettes: Safe or Harmful?
US News and World Report – Feb. 15
The catch is that nicotine patches and gum aren't nearly as popular as e-cigarettes, says Thomas Brandon, head of the Health Outcomes and Behavior Program with the Moffitt Cancer Center in Tampa, Florida. "In terms of a larger public-health perspective, a lot more people are using e-cigarettes than are using those nicotine-replacement products," Brandon says. "So it might be something we want to capitalize on."

Regional chemotherapy technique for extremity sarcoma salvages limbs from amputation
Medical Xpress – Feb. 15
"Isolated limb infusion is a safe and effective technique of treatment of patients with locally advanced soft tissue sarcoma who otherwise might require amputation," said lead study author John E. Mullinax, MD, from Moffitt Cancer Center, Tampa, Fla.

Using emotion to guide palliative treatment
Journal of Clinical Pathways – January/February 2017 Issue
Journal of Clinical Pathways spoke with one of the study’s presenters, Benjamin Djulbegovic, MD, PhD, a member of Moffitt’s health outcomes and behavior program and distinguished professor at University of South Florida Morsani College of Medicine (Tampa, FL), about the need for effective entry points to discuss palliative care possibilities with this patient population, as well as the value of emotion-based decision-making tools.

In the Next Generation of Value-Based Contracting, Clinical Pathways Can Increase Accountability
Journal of Clinical Pathways – January/February 2017 Issue
Author: Cynthia Terrano, Moffitt Cancer Center                       

Regional chemotherapy technique for extremity sarcoma salvages limbs from amputation
eCancer News – Feb. 15
"Isolated limb infusion is a safe and effective technique of treatment of patients with locally advanced soft tissue sarcoma who otherwise might require amputation," said lead study author John E. Mullinax, MD, from Moffitt Cancer Center, Tampa, Fla.

Vaccine Shows Promising Results for Early-Stage Breast Cancer Patients
Cancer Connect – Feb. 15
Doctors at Moffitt Cancer Center in Tampa Florida are working on a promising new vaccine that would help early-stage breast cancer patients who have HER2 positive disease.

Variety show to benefit Moffitt Cancer Center
Tampa Bay Newspapers – Feb. 14
Cancer is a great equalizer, said Zena Bond, producer of an annual musical variety show that raises funds for the Moffitt Cancer Center in Tampa.

Strosberg Discusses Latest Lutathera Data in Midgut Neuroendocrine Tumors
OncLive – Feb. 14
In an interview with OncLive, lead NETTER-1 author Jonathan Strosberg, MD, medical oncologist, Department of Gastrointestinal Oncology, section head, Neuroendocrine Division, chair, Gastrointestinal Department Research Program, Moffitt Cancer Center, discussed the latest results from the NETTER-1 trial, which were published in January in The New England Journal of Medicine.

Immunotherapy needs new value framework, say SITC 2016 attendees
Immuno-Oncology News – Feb. 14
This new model could include benefits shown via positive clinical trial results, as well as patient-reported outcomes (PROs), say Heather S. Jim, PhD, associate member at Moffitt Cancer Center, and Adam P. Dicker, MD, PhD, senior vice president and chair of radiation oncology at Thomas Jefferson University.

Vaccine Shows Promising Results for Early-Stage Breast Cancer Patients
Cancer Connect – Feb. 14
Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Doctors at Moffitt Cancer Center in Tampa Florida are working on a promising new vaccine that would help early-stage breast cancer patients who have HER2 positive disease.

The outlook for HIPAA and cybersecurity enforcement under new HHS Secretary Tom Price
Fierce Healthcare – Feb. 14
Dave Summitt, CISO and director of cybersecurity operations at Moffitt Cancer Center, told GovInfoSecurity that easing cybersecurity regulations embedded in HIPAA and the HITECH Act would have a detrimental impact given the healthcare industry’s subpar approach to cybersecurity.

What Happened in Vegas: Highlights from the 2017 Cancer Center Business Summit
Association of Community Cancer Centers – Feb. 14
And panelist Cynthia Terrano, Vice President Payer Strategies, Moffitt Cancer Center, noted the importance of getting payers involved in the conversation. “The train has left the station on APMs,” she told meeting attendees. “Cancer programs need to reach out to their payers now to develop partnerships and experiment with different alternative payment models.”

Revenue cycle teams add work-from-home options, improving productivity
Healthcare Finance News – Feb. 13
"In the last two years, technological advances, and people's ability to do things anytime, anywhere have just become so ingrained in our culture that it's become a natural progression -- to be able to work from home and have a little flexibility," said Lynne Hildreth, director of patient access at the Florida-based Moffitt Cancer Center, which has seen its work-from-home program become popular among its employees during the first year of implementation.

Moffitt holds second annual ‘hug a science teacher’ day in Hillsborough
WFLA – Feb. 13
The Moffitt Cancer Center is holding its second annual ‘hug a science teacher’ day for Hillsborough County teachers.Close to 50 Hillsborough County teachers will get a first-hand look at the world-class center to later use as a teaching tool.

This Woman Found Her Breast Cancer With a Move Doctors Want You to Try
Self Magazine – Feb. 10
In fact, he adds, it can be easier to detect a lump when a patient is lying down. Brian Czerniecki, M.D., chairman of the department of breast oncology at Moffitt Cancer Center, agrees. “The geometry of the breast flattens and spreads out, sometimes making lumps easier to feel,” he tells SELF.

CAR T-Cell Therapy Is Safe, Effective in Lymphoma
CureToday – Feb. 10
Frederick Locke, M.D., a medical oncologist at Moffitt Cancer Center, Tampa, Florida, and colleagues reported an overall response rate of 71 percent (five of seven patients) including four patients who developed a rapid CR within one month of treatment.

Treatment of Midgut Neuroendocrine Tumors
Cancer Network – Feb. 10
In this video, Jonathan Strosberg, MD, of the Moffitt Cancer Center, discusses current options for the treatment of midgut neuroendocrine tumors; highlights results of the NETTER-1 trial, which showed improved progression-free survival with lutetium-177 (177Lu)–Dotatate in this patient population; and discusses the use of radionuclide therapy in other types of neuroendocrine tumors.

Expert Point of View: Amber Orman, MD
ASCO Post – Feb. 10
Amber Orman, MD, of the Department of Radiation Oncology, Breast Section, at Moffitt Cancer Center in Tampa, Florida, who was not involved in this study, said: “This study provides guidance when deciding how best to integrate postmastectomy reconstruction and radiation therapy.

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.